EPHB2 is not only involved in glutamatergic neurotransmission but also simultaneously participates in the inflammation regulation process in some brain diseases including stroke, anxiety and Alzheimer’s disease (Coulthard et al., 2012; Dines and Lamprecht, 2016; Ernst et al., 2019). Here, EPHB2 is linked to early-onset autosomal dominant Alzheimer disease.